158 related articles for article (PubMed ID: 16415694)
1. A comparison of gatifloxacin to ciprofloxacin in the prophylaxis of Streptococcus pneumoniae in rabbits in a LASIK model.
Donnenfeld RS; Perry HD; Solomon R; Jensen HG; Stein J; Snyder RW; Wittpenn JR; Donnenfeld ED
Eye Contact Lens; 2006 Jan; 32(1):46-50. PubMed ID: 16415694
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Tungsiripat T; Sarayba MA; Kaufman MB; Sweet PM; Taban M; Carpenter TR; McDonnell PJ
Am J Ophthalmol; 2003 Jul; 136(1):76-81. PubMed ID: 12834673
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
Jensen H; Zerouala C; Carrier M; Short B
J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Sarayba MA; Shamie N; Reiser BJ; Sweet PM; Taban M; Graff JM; Kesler-Diaz A; Osann KE; McDonnell PJ
J Cataract Refract Surg; 2005 Jul; 31(7):1396-402. PubMed ID: 16105613
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic gatifloxacin therapy in prevention of bacterial keratitis in a rabbit laser in situ keratomileusis model.
Slade DS; Friday JW; Snyder RW; Nix DE; Kleinert LB; Patula VB
J Cataract Refract Surg; 2007 May; 33(5):888-92. PubMed ID: 17466866
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal keratitis after laser in situ keratomileusis.
Dada T; Sharma N; Dada VK; Vajpayee RB
J Cataract Refract Surg; 2000 Mar; 26(3):460-1. PubMed ID: 10713245
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
[TBL] [Abstract][Full Text] [Related]
10. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
[TBL] [Abstract][Full Text] [Related]
11. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
[TBL] [Abstract][Full Text] [Related]
13. Two cases of pneumococcal keratitis following myopic LASIK.
Lifshitz T; Levy J; Raiskup F; Klemperer I; Frucht-Pery J
J Refract Surg; 2005; 21(5):498-501. PubMed ID: 16209450
[TBL] [Abstract][Full Text] [Related]
14. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Prasanth DA; Thomas PA; Jesudasan CA
Am J Ophthalmol; 2006 Feb; 141(2):282-286. PubMed ID: 16458681
[TBL] [Abstract][Full Text] [Related]
15. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
[TBL] [Abstract][Full Text] [Related]
16. Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.
Herrygers LA; Noecker RJ; Lane LC; Levine JM
Cornea; 2005 Jan; 24(1):66-71. PubMed ID: 15604869
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Thibodeaux BA; Traidej M; Austin MS; Marquart ME; Stroman DW; O'Callaghan RJ
Cornea; 2001 Nov; 20(8):878-80. PubMed ID: 11685070
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
19. Lomefloxacin is an effective treatment of experimental bacterial keratitis.
Kowalski RP; Romanowski EG; Yates KA; Gordon YJ
Cornea; 2001 Apr; 20(3):306-8. PubMed ID: 11322421
[TBL] [Abstract][Full Text] [Related]
20. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.
Hamam RN; Noureddin B; Salti HI; Haddad R; Khoury JM
Ophthalmology; 2006 Jun; 113(6):950-4. PubMed ID: 16647126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
